Skip to main content
. 2017 Sep 7;17:123. doi: 10.1186/s12890-017-0466-7

Table 1.

Clinical features of patients who underwent hematopoietic stem cell transplantation complicated with severe late-onset idiopathic pneumonia syndrome

Case Sex Primary disease Age at HSCT Type of donor/Stem cells HLA compatibility Conditioning regimen GVHD prophylaxis Grades of acute GVHD Type of chronic GVHD [1] Organs of chronic GVHD Months from HSCT to Dx of chronic GVHD Smoking history History of Infections Out-come
1 M ALL 48 UR/BM DR serological
1 locus mismatch
TBI (12 Gy)
CY
TAC + MTX II Extensive M, E, L 7.0 CMV Retinitis Adenovirus cystitis
Bacterial pneumonia
Dead
2 F MDS 43 UR/BM complete match TBI (12 Gy)
CyA
TAC + MTX II Extensive S, M, E, L 9.4 Bacterial pneumonia Influenza virus bronchitis Alive
3 M AML 12 UR/BM complete match TBI (12 Gy)
CyA, CY
TAC + MTX II Extensive S, M, E, L 4.4 MRSA pleuritis Dead
4 F ALL 53 UR/BM complete match TBI (12 Gy)
CyA, CY
TAC + MTX I Extensive S, M 3.7 CMV enterocolitis Alive
5 F CML 35 UR/BM DRB1 1 allele mismatch TBI (12 Gy)
CyA, CY
TAC + MTX III Extensive S, M, E, G 4.1 Dead
6 F ALL 32 R/BM complete match BU, CY CyA + MTX 0 Extensive E, L 4.8 Aspergillus pneumonia
Listeria bacteremia
Dead
7 M MM 39 UR/BM DRB1 1 allele mismatch Flu, L-PAM TAC + MTX I Extensive S, E 2.2 Bacterial pneumonia HHV6 encephalomyelitis Dead
8 F ALL 49 R/BM complete match TBI (12 Gy)
CyA, CY
CyA + MTX III Extensive M,G 4.9 Pseudomonas pneumonia CMV infection (unknown focus) Dead
9 M AML 31 UR/BM DRB1 1 allele mismatch TBI (12 Gy)
CyA
TAC + MTX II Extensive S, M, E 4.0 Bacterial pneumonia, CMV infection (unknown focus) Alive
10 M AML 44 UR/BM A 1 allele mismatch TBI (12 Gy)
CyA
TAC + MTX I Extensive S, M, E, L 4.5 + Cholecystitis
CMV infection (unknown focus)
Dead
11 F CML 33 UR/ BM complete match TBI (12 Gy)
CyA
TAC + MTX I Extensive S, M, E, L 3.2 Bacterial pneumonia Alive
12 M ALL 43 UR/BM complete match TBI (12 Gy)
CyA, CY
TAC + MTX III Extensive S, M, E, L 46.4 Dead

M male, F female, ALL acute lymphocytic leukemia, MDS myelodysplastic syndrome; AML acute myeloid leukemia, CML chronic myelogenous leukemia, MM multiple myeloma, HSCT hematopoietic stem cell transplantation, UR unrelated, R related, BM bone marrow cells, HLA human leukocyte antigen, TBI total body irradiation, CY cyclophosphamide, CyA cyclosporine A, BU busulphan, Flu fludarabine, L-PAM melphalan, GVHD graft-versus-host disease, TAC tacrolimus, MTX methotrexate, M mouth, E eye, L liver, S skin, G gastrointestinal tract, Dx diagnosis, HHV6 human herpesvirus 6